Epilepsies, Partial
Information
- Disease name
- Epilepsies, Partial
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT03689114 | Active, not recruiting | Phase 4 | Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) | May 10, 2021 | August 31, 2024 |
NCT00072813 | Completed | MRI in Autosomal Dominant Partial Epilepsy With Auditory Features | November 10, 2003 | ||
NCT00143143 | Completed | Phase 3 | Pregabalin Open-Label Extension Trial in Patients With Partial Seizures | September 2001 | February 2006 |
NCT00151879 | Completed | Phase 2/Phase 3 | Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures | February 2005 | May 2006 |
NCT00210522 | Completed | Phase 2 | An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy | May 2005 | June 2010 |
NCT00210652 | Completed | Phase 2 | An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy | July 2004 | March 2010 |
NCT00212745 | Completed | Phase 1/Phase 2 | Pilot Trial of a Behavioral Treatment for Epilepsy | February 2004 | March 2009 |
NCT00230698 | Completed | Phase 3 | A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure | November 1995 | August 2002 |
NCT00231556 | Completed | Phase 3 | A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy | July 1999 | September 2003 |
NCT00236691 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. | July 1988 | December 1990 |
NCT00236730 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy | June 1988 | December 1990 |
NCT00050934 | Completed | Phase 3 | Pediatric Epilepsy Study | June 2002 | June 2004 |
NCT00236847 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. | December 1989 | July 1993 |
NCT00236860 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures | May 1989 | February 1992 |
NCT00236873 | Completed | Phase 2 | A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. | October 1989 | May 1993 |
NCT00236886 | Completed | Phase 3 | Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients | May 1998 | June 2000 |
NCT00266604 | Completed | Phase 4 | A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy | December 2005 | June 2007 |
NCT00280696 | Completed | Phase 3 | A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures | November 2005 | November 2007 |
NCT00319501 | Completed | Phase 3 | Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. | January 2006 | July 2014 |
NCT00351611 | Completed | Phase 4 | Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo | July 26, 2006 | February 4, 2020 |
NCT00236743 | Completed | Phase 3 | A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy | June 1994 | October 2000 |
NCT00643136 | Completed | Phase 3 | A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures | November 2002 | June 2004 |
NCT00771927 | Completed | Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures | October 2008 | March 2012 | |
NCT00772603 | Completed | Phase 3 | Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures | November 2008 | November 2010 |
NCT00918047 | Completed | Phase 1 | Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients | June 2009 | November 2010 |
NCT00991757 | Completed | Phase 3 | An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. | February 2007 | October 2010 |
NCT01098162 | Completed | Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug | March 2010 | July 2013 | |
NCT01262677 | Completed | Phase 3 | Once-A-Day Pregabalin For Partial Seizures | February 17, 2011 | August 1, 2012 |
NCT01441401 | Completed | Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan) | December 2011 | September 2014 | |
NCT01663545 | Completed | Brain P-gp and Inflammation in People With Epilepsy | July 31, 2012 | October 4, 2017 | |
NCT01745952 | Completed | N/A | Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS) | November 2012 | December 31, 2015 |
NCT03200769 | Completed | N/A | Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy | July 21, 2014 | July 2021 |
NCT03446664 | Completed | N/A | Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study | February 27, 2018 | October 27, 2021 |
NCT05273398 | Completed | Phase 4 | Effects of Diazepam on RNS Detections | March 1, 2022 | November 10, 2022 |
NCT00437281 | Completed | Phase 1/Phase 2 | Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures | April 2007 | November 2012 |
NCT00448916 | Completed | Phase 3 | Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures | May 2007 | October 2013 |
NCT00512317 | Completed | Phase 2 | Open-label Extension to Protocol 1042-0600 | June 2007 | September 2013 |
NCT00537940 | Completed | Phase 4 | Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures | February 2008 | July 2013 |
NCT00567268 | Completed | Drug Use Investigation Of Gabapentin | August 2007 | May 2014 | |
NCT00603473 | Completed | Phase 3 | A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures | January 2008 | December 2009 |
NCT00620555 | Completed | Phase 3 | A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures | May 2008 | December 2010 |
NCT04309812 | Enrolling by invitation | Early Phase 1 | Transcranial Direct Current to Treat Epilepsy at Home | May 26, 2021 | July 26, 2023 |
NCT05248269 | Enrolling by invitation | N/A | Thermocoagulation in Drug Resistant Focal Epilepsy | February 7, 2022 | December 1, 2024 |
NCT03559673 | No longer available | Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures | |||
NCT06374966 | Not yet recruiting | Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy | April 2024 | December 2025 | |
NCT05015868 | Recruiting | N/A | Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies | July 15, 2021 | December 31, 2024 |
NCT03949478 | Recruiting | Phase 2 | Treating Postictal Symptoms Using Ibuprofen and Nifedipine | February 1, 2021 | March 1, 2025 |
NCT03054961 | Recruiting | Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study | February 10, 2017 | February 9, 2025 | |
NCT00524030 | Terminated | Phase 3 | Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures | September 2007 | June 2011 |
NCT00215215 | Terminated | Phase 4 | Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures | February 2005 | November 2007 |
NCT02635633 | Terminated | N/A | Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept | August 2015 | September 2018 |
NCT03916848 | Unknown status | N/A | Novel Network Analysis of Intracranial Stereoelectroencephalography | June 16, 2019 | April 2022 |
NCT03882151 | Unknown status | N/A | Added Value of Automated Electrical Source Localization (EPILOG PreOp®) to Presurgical Evaluation of Refractory Epilepsy | January 15, 2019 | December 31, 2020 |
NCT00422110 | Withdrawn | Phase 2/Phase 3 | A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures | May 2008 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004828